Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 4
2004 5
2005 1
2006 4
2007 1
2009 1
2019 1
2021 4
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Aprotinin and Avifavir® Combination Therapy for Moderate COVID-19 Patients.
Ivashchenko AA, Azarova VN, Egorova AN, Karapetian RN, Kravchenko DV, Krivonos NV, Loginov VG, Poyarkov SV, Merkulova EA, Rosinkova OS, Savchuk NP, Topr MA, Simakina EN, Yakubova EV, Ivachtchenko AV. Ivashchenko AA, et al. Among authors: savchuk np. Viruses. 2021 Jun 27;13(7):1253. doi: 10.3390/v13071253. Viruses. 2021. PMID: 34199134 Free PMC article.
Reply to Krishna Prabha et al.
Ivashchenko AA, Savchuk NP, Yakubova EV, Ivachtchenko AV. Ivashchenko AA, et al. Among authors: savchuk np. Clin Infect Dis. 2021 Aug 2;73(3):e848-e849. doi: 10.1093/cid/ciaa1606. Clin Infect Dis. 2021. PMID: 33099607 No abstract available.
AVIFAVIR for Treatment of Patients With Moderate Coronavirus Disease 2019 (COVID-19): Interim Results of a Phase II/III Multicenter Randomized Clinical Trial.
Ivashchenko AA, Dmitriev KA, Vostokova NV, Azarova VN, Blinow AA, Egorova AN, Gordeev IG, Ilin AP, Karapetian RN, Kravchenko DV, Lomakin NV, Merkulova EA, Papazova NA, Pavlikova EP, Savchuk NP, Simakina EN, Sitdekov TA, Smolyarchuk EA, Tikhomolova EG, Yakubova EV, Ivachtchenko AV. Ivashchenko AA, et al. Among authors: savchuk np. Clin Infect Dis. 2021 Aug 2;73(3):531-534. doi: 10.1093/cid/ciaa1176. Clin Infect Dis. 2021. PMID: 32770240 Free PMC article. Clinical Trial.
A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling.
Revankar CM, Bologa CG, Pepermans RA, Sharma G, Petrie WK, Alcon SN, Field AS, Ramesh C, Parker MA, Savchuk NP, Sklar LA, Hathaway HJ, Arterburn JB, Oprea TI, Prossnitz ER. Revankar CM, et al. Among authors: savchuk np. Cell Chem Biol. 2019 Dec 19;26(12):1692-1702.e5. doi: 10.1016/j.chembiol.2019.10.009. Epub 2019 Nov 6. Cell Chem Biol. 2019. PMID: 31706983 Free PMC article.
Computational mapping tools for drug discovery.
Ivanenkov YA, Savchuk NP, Ekins S, Balakin KV. Ivanenkov YA, et al. Among authors: savchuk np. Drug Discov Today. 2009 Aug;14(15-16):767-75. doi: 10.1016/j.drudis.2009.05.016. Epub 2009 Jun 9. Drug Discov Today. 2009. PMID: 19520185 Review.
Recent progress in discovery and development of antimitotic agents.
Kiselyov A, Balakin KV, Tkachenko SE, Savchuk N, Ivachtchenko AV. Kiselyov A, et al. Among authors: savchuk n. Anticancer Agents Med Chem. 2007 Mar;7(2):189-208. doi: 10.2174/187152007780058650. Anticancer Agents Med Chem. 2007. PMID: 17348827 Review.
25 results